AgeX Therapeutics, Inc. (AGE)

R&D Expenses

$14.07M

TTM · Period ending: · USD

AGE logo

AGE R&D Expenses

Latest reported$14.07M
AGE TTM R&D Expenses ($6.63M → $14.07M)
High-resolution chart · PNG

AGE r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
14,067,000
13,403,000
13,155,000
15,761,000
14,525,000
12,967,000
11,122,000
5,264,000
3,067,000
1,633,000
701,000
760,000
704,000
803,000
1,025,000
1,193,000
1,306,000
1,528,000
1,456,000
2,266,000
2,830,000
3,699,000
4,978,000
5,261,000
5,869,000
6,169,000
5,904,000
5,958,000
5,843,000
5,577,000
6,630,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.